BackTable / Tumor Board / Podcast / Episode #18

Intermediate Risk NMIBC: Patient-Centered Treatment Strategies

with Dr. Kelly Bree

Counseling patients with intermediate-risk non-muscle invasive bladder cancer can be complex, with a wide range of treatment options and care pathways. In this episode of BackTable, urologic oncologists Dr. Ruchika Talwar and Dr. Kelly Bree explore how to approach this challenge with clarity and compassion.

This podcast is supported by an educational grant from UroGen Pharma. UGN-102 was approved by the FDA on June 12, 2025.

UroGen Pharma

Intermediate Risk NMIBC: Patient-Centered Treatment Strategies with Dr. Kelly Bree on the BackTable Tumor Board Podcast

Ep 18 Intermediate Risk NMIBC: Patient-Centered Treatment Strategies with Dr. Kelly Bree

00:00 / 01:04

BackTable, LLC (Producer). (2025, June 10). Ep. 18 – Intermediate Risk NMIBC: Patient-Centered Treatment Strategies [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Podcast Contributors

Dr. Kelly Bree

Dr. Kelly Bree is a urologic oncologist and Assistant Professor of Urology at MD Anderson Cancer Center in Houston, Texas.

Dr. Ruchika Talwar

Dr. Ruchika Talwar is a urologic oncologist at Vanderbilt University Medical Center in Nashville, Tennessee.

Synopsis

They emphasize a shift toward patient-centered, less aggressive treatment strategies, highlighting the importance of quality of life in clinical decision-making. The discussion includes risk stratification, the use of intravesical gemcitabine, and ongoing clinical trials. Dr. Bree also offers actionable tips for optimizing patient preparation and recovery. This episode underscores the growing importance of listening to patient voices to shape future standards of care.

Timestamps

00:00 - Introduction
02:09 - Risk Stratification and Treatment Approaches
06:12 - Intravesical Therapy Options
08:47 - Quality of Life and Patient Counseling
12:56 - Practical Tips for TURBT Recovery
17:03 - In-Office Procedure Management
21:23 - Resources and Support for Patients
24:13 - Final Thoughts

Resources

Society of Urologic Oncology
https://suonet.org/home.aspx

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Up Next

NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee and Dr. Scott Genshaft on the BackTable Tumor Board Podcast

Keynote-689: Implementation & Multidisciplinary Care for Immunotherapy in Head & Neck Cancer with Dr. Adam Luginbuhl, Dr. Jennifer Johnson, Dr. Mihir Patel and Dr. Siddharth Sheth on the BackTable Tumor Board Podcast

Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes and Dr. Lingling Du on the BackTable Tumor Board Podcast

Articles

Topics

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.